Paper24928124
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.
Ryman DC and 25 others. Neurology, 2014. Cited by 425 papers, by iCite.
Cite this record
ConductScience Library. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Papers, record 24928124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24928124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Age of Onset | Major topic |
| Alzheimer Disease | Major topic |
| Chromosome Disorders | Major topic |
| Genes, Dominant | Major topic |
| Humans |
Source PubMed
Grants16
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 GM046255 | NIGMS NIH HHS | United States | R01GM046255 | PubMed and NIH | NIH RePORTER |
| GM 46255 | NIGMS NIH HHS | United States | R01GM046255 | PubMed and NIH | NIH RePORTER |
| P50 AG005136 | NIA NIH HHS | United States | P50AG005136 | PubMed and NIH | NIH RePORTER |
| R37 AG011762 | NIA NIH HHS | United States | R01AG011762 | PubMed and NIH | NIH RePORTER |
| P50 AG005134 | NIA NIH HHS | United States | P50AG005134 | PubMed and NIH | NIH RePORTER |
| R01 AG021544 | NIA NIH HHS | United States | R01AG021544 | PubMed and NIH | NIH RePORTER |
| R37 GM046255 | NIGMS NIH HHS | United States | R01GM046255 | PubMed and NIH | NIH RePORTER |
| AG 05136 | NIA NIH HHS | United States | P50AG005136 | PubMed and NIH | NIH RePORTER |
| P30 AG062421 | NIA NIH HHS | United States | P30AG062421 | PubMed | NIH RePORTER |
| U19 AG010483 | NIA NIH HHS | United States | U19AG010483 | PubMed and NIH | NIH RePORTER |
| AG 21544 | NIA NIH HHS | United States | R01AG021544 | PubMed and NIH | NIH RePORTER |
| R01 AG011762 | NIA NIH HHS | United States | R01AG011762 | PubMed and NIH | NIH RePORTER |
| AG 11762 | NIA NIH HHS | United States | R01AG011762 | PubMed and NIH | NIH RePORTER |
| U19 AG032438 | NIA NIH HHS | United States | U19AG032438 | PubMed and NIH | NIH RePORTER |
| R37AG011762 | NIH | NIH RePORTER | |||
| R37GM046255 | NIH | NIH RePORTER |
Trials6
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01760005 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 | Background | ClinicalTrials.gov | |
| NCT04623242 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. | Background | ClinicalTrials.gov | |
| NCT05552157 | A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation | Background | ClinicalTrials.gov | |
| NCT06384573 | DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease | Background | ClinicalTrials.gov | |
| NCT06424236 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation | Background | ClinicalTrials.gov | |
| NCT06647498 | A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation | Background | ClinicalTrials.gov |
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9343467 | Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. | JAMA | 1997 | https://conductscience.org/library/papers/9343467 | PubMed |
| 2 | 16267640 | Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. | J Neurol | 2006 | https://conductscience.org/library/papers/16267640 | PubMed |
| 3 | 16327343 | Survival among patients with dementia from a large multi-ethnic population. | Alzheimer Dis Assoc Disord | 2005 | https://conductscience.org/library/papers/16327343 | PubMed |
| 4 | 11395394 | Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. | Am J Pathol | 2001 | https://conductscience.org/library/papers/11395394 | PubMed |
| 5 | 21971471 | Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. | J Alzheimers Dis | 2011 | https://conductscience.org/library/papers/21971471 | PubMed |
| 6 | 9052708 | Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. | JAMA | 1997 | https://conductscience.org/library/papers/9052708 | PubMed |
| 7 | 17192785 | Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. | Nat Genet | 2007 | https://conductscience.org/library/papers/17192785 | PubMed |
| 8 | 18667258 | Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. | Neurobiol Aging | 2010 | https://conductscience.org/library/papers/18667258 | PubMed |
| 9 | 22997326 | Preventing Alzheimer's disease. | Science | 2012 | https://conductscience.org/library/papers/22997326 | PubMed |
| 10 | 15389756 | APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation. | Am J Med Genet B Neuropsychiatr Genet | 2005 | https://conductscience.org/library/papers/15389756 | PubMed |
| 11 | 7023604 | The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. | Brain | 1981 | https://conductscience.org/library/papers/7023604 | PubMed |
| 12 | 12891668 | Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred. | Ann Neurol | 2003 | https://conductscience.org/library/papers/12891668 | PubMed |
| 13 | 20375137 | Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. | Brain | 2010 | https://conductscience.org/library/papers/20375137 | PubMed |
| 14 | 21211070 | Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. | Alzheimers Res Ther | 2011 | https://conductscience.org/library/papers/21211070 | PubMed |
| 15 | 24131566 | Dominantly Inherited Alzheimer Network: facilitating research and clinical trials. | Alzheimers Res Ther | 2013 | https://conductscience.org/library/papers/24131566 | PubMed |
| 16 | 2025423 | Familial Alzheimer disease: a large, multigeneration German kindred. | Alzheimer Dis Assoc Disord | 1991 | https://conductscience.org/library/papers/2025423 | PubMed |
| 17 | 19604328 | What is 'early onset dementia'? | Psychogeriatrics | 2009 | https://conductscience.org/library/papers/19604328 | PubMed |
| 18 | 14560058 | A method for estimating duration of illness in Alzheimer's disease. | Dement Geriatr Cogn Disord | 2004 | https://conductscience.org/library/papers/14560058 | PubMed |
| 19 | 3345066 | Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect. | Ann Neurol | 1988 | https://conductscience.org/library/papers/3345066 | PubMed |
| 20 | 23246540 | A presenilin 1 mutation in the first case of Alzheimer's disease. | Lancet Neurol | 2013 | https://conductscience.org/library/papers/23246540 | PubMed |
Cited by338
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 425 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42877385 | The single cell origin of sporadic Alzheimer's disease: A developmental biallelic somatic mutation model. | J Alzheimers Dis Rep | 2026 | https://conductscience.org/library/papers/42877385 | PubMed |
| 42856312 | Gantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease. | medRxiv | 2026 | https://conductscience.org/library/papers/42856312 | PubMed |
| 42853147 | Autoantibodies neutralizing type I interferons in older twin pairs: Low concordance. | J Hum Immun | 2026 | https://conductscience.org/library/papers/42853147 | PubMed |
| 42781715 | Technology-natives and technology-adopters: Age differences in remote cognitive assessment in Alzheimer disease. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42781715 | PubMed |
| 42740027 | Electrodermal Activity as a Potential Diagnostic Biomarker for Alzheimer's Disease: A Pilot Study. | Sensors (Basel) | 2026 | https://conductscience.org/library/papers/42740027 | PubMed |
| 42719037 | Remote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studies. | Alzheimers Dement (N Y) | 2026 | https://conductscience.org/library/papers/42719037 | PubMed |
| 42637536 | Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing. | J Neurol Neurosurg Psychiatry | 2026 | https://conductscience.org/library/papers/42637536 | PubMed |
| 42597443 | Toward personalized medicine in AD/ADRD through genetic-exposome dementia risk assessments. | NPJ Dement | 2026 | https://conductscience.org/library/papers/42597443 | PubMed |
| 42569826 | APOE and genetic risk variants influence Alzheimer's disease onset in carriers of an extra copy of APP, with and without Down syndrome. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42569826 | PubMed |
| 42395104 | Novel PSEN1 (Q223 L) mutation causes early-onset Alzheimer's disease: A case report. | World J Radiol | 2026 | https://conductscience.org/library/papers/42395104 | PubMed |
| 42204862 | Recommendations for genetic counseling for individuals at risk of autosomal dominant Alzheimer's disease in Latin America. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42204862 | PubMed |
| 42022292 | Unbiased data-driven analysis of five amyloid-beta peptides for biomarker investigations in familial Alzheimer's disease. | Brain Commun | 2026 | https://conductscience.org/library/papers/42022292 | PubMed |
| 42020929 | Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's disease. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42020929 | PubMed |
| 41964075 | Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairment. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/41964075 | PubMed |
| 41959774 | Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer's Disease. | medRxiv | 2026 | https://conductscience.org/library/papers/41959774 | PubMed |
| 41959760 | Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing. | medRxiv | 2026 | https://conductscience.org/library/papers/41959760 | PubMed |
| 41913983 | Screening and functional validations of APP , PSEN1 , and PSEN2 mutations from PUMCH dementia cohort. | Chin Med J (Engl) | 2026 | https://conductscience.org/library/papers/41913983 | PubMed |
| 41851792 | Clinical, neuroimaging, and biomarker profiling of four Alzheimer's disease pedigrees caused by pathogenic APP variants. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/41851792 | PubMed |
| 41757216 | Plasma Proteomic Analysis of APOE ε4 Homozygotes Identifies Preclinical Alzheimer's Disease Alterations Potentially Treatable with Semaglutide. | medRxiv | 2026 | https://conductscience.org/library/papers/41757216 | PubMed |
| 41748785 | Magnetic resonance microscopy maps widespread effects of Alzheimer's disease on brain structures and behavior in mice. | Nat Neurosci | 2026 | https://conductscience.org/library/papers/41748785 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| PSEN1 | 5663 | PubTator's text mining | https://conductscience.org/library/genes/5663 | NCBI Gene |
| PSEN2 | 5664 | PubTator's text mining | https://conductscience.org/library/genes/5664 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24928124
GET https://conductscience.org/api/papers/v1/24928124/authors?page=2